X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10) 10
tyrosine (9) 9
brain tumors (8) 8
male (8) 8
humans (7) 7
pet (6) 6
aged (5) 5
female (5) 5
positron emission tomography (5) 5
radiology, nuclear medicine & medical imaging (5) 5
tyrosine - analogs & derivatives (5) 5
animals (4) 4
brain cancer (4) 4
f-18-fet pet (4) 4
phenols (4) 4
tomography (4) 4
tumors (4) 4
valuable diagnostic-tool (4) 4
brain (3) 3
brain neoplasms - diagnostic imaging (3) 3
brain neoplasms - metabolism (3) 3
clinical neurology (3) 3
dexamethasone (3) 3
fet pet (3) 3
glioma (3) 3
glioma - diagnostic imaging (3) 3
gliomas (3) 3
kinetics (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
metastasis (3) 3
o-(2- (3) 3
o--l-tyrosine (3) 3
patients (3) 3
peripheral vascular disease (3) 3
pets (3) 3
prognostic value (3) 3
rats (3) 3
therapy (3) 3
tumor (3) 3
tyrosin (3) 3
uptake kinetics (3) 3
abstracts (2) 2
accuracy (2) 2
adolescent (2) 2
atorvastatin calcium (2) 2
blood-brain barrier (2) 2
blood-brain barrier - diagnostic imaging (2) 2
blood-brain barrier - drug effects (2) 2
brain metastasis (2) 2
cardiovascular diseases - prevention & control (2) 2
cerebral gliomas (2) 2
cholesterol (2) 2
clinical medicine (2) 2
corticosteroids (2) 2
diagnostic systems (2) 2
experimentalstudie (2) 2
f-fet pet (2) 2
f]fluoroethyl-l-tyrosine (2) 2
fluorine isotopes (2) 2
gehirn (2) 2
gehirntumor (2) 2
gender (2) 2
glioma - metabolism (2) 2
guidelines (2) 2
hemodialysis (2) 2
heterogeneity (2) 2
high-grade glioma (2) 2
imaging / radiology (2) 2
implantat (2) 2
intracranial tumors (2) 2
kidney failure, chronic - complications (2) 2
kinetik (2) 2
klinisk medicin (2) 2
lipids (2) 2
magnetic resonance imaging (2) 2
medicine (2) 2
medicine & public health (2) 2
metastases (2) 2
middle aged (2) 2
nuclear medicine (2) 2
oncology (2) 2
permeability (2) 2
pet imaging (2) 2
positron emission (2) 2
positron-emission tomography - methods (2) 2
positron-emission-tomography (2) 2
pravastatin (2) 2
prospective studies (2) 2
quantitative analysis (2) 2
radiopharmaceuticals - pharmacokinetics (2) 2
ratte (2) 2
recurrent glioma (2) 2
reproducibility of results (2) 2
response assessment (2) 2
risk factors (2) 2
stroke outcome (2) 2
sweden (2) 2
taxation (2) 2
treatment outcome (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Nuclear Medicine, ISSN 0161-5505, 05/2017, Volume 58, Issue 5, pp. 700 - 705
Restoration of the blood-brain barrier (BBB) after antiangiogenic therapy of gliomas with bevacizumab may result in a decrease in contrast enhancement on MRI... 
F-FET PET | Evans blue dye | Blood-brain barrier | PET | Glioblastoma | Bevacizumab | blood-brain barrier | RECURRENT GLIOMA | AMINO-ACID PET | VALUABLE DIAGNOSTIC-TOOL | RESPONSE ASSESSMENT | PROGNOSTIC VALUE | UPTAKE KINETICS | F-18-FET PET | glioblastoma | POSITRON-EMISSION-TOMOGRAPHY | NEUROONCOLOGY WORKING GROUP | bevacizumab | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | HIGH-GRADE GLIOMA | Reproducibility of Results | Radiopharmaceuticals - pharmacokinetics | Bevacizumab - administration & dosage | Brain Neoplasms - diagnostic imaging | Capillary Permeability - drug effects | Rats | Male | Positron-Emission Tomography - methods | Blood-Brain Barrier - drug effects | Tyrosine - analogs & derivatives | Brain Neoplasms - metabolism | Glioma - metabolism | Animals | Blood-Brain Barrier - diagnostic imaging | Glioma - diagnostic imaging | Sensitivity and Specificity | Tyrosine - pharmacokinetics | Therapy | Nuclear magnetic resonance--NMR | Brain tumors | Membrane permeability | Fluorescence | Restoration | Neostriatum | Xenografts | Tomography | Tyrosine | Immunodeficiency | Positron emission | Histology | Permeability | Studies | Autoradiography | Magnetic resonance imaging | Antiangiogenics | Influence | Glioblastoma cells | Diagnostic systems | Positron emission tomography | Viability | Tumors | Long-term effects | Index Medicus
Journal Article
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 13328 - 9
Mutations in the isocitrate dehydrogenase (IDH mut) gene have gained paramount importance for the prognosis of glioma patients. To date, reliable techniques... 
TEXTURAL FEATURES | SURVIVAL | HETEROGENEITY | MUTATION STATUS | MULTIDISCIPLINARY SCIENCES | VINCRISTINE | GRADE | CLASSIFICATION | TUMORS | PROCARBAZINE | CARCINOMA | Tyrosine | Genotype & phenotype | Accuracy | Glioma | Surgery | Scanners | Isocitrate dehydrogenase | Positron emission tomography | Genotypes
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 05/2017, Volume 58, Issue 5, pp. 700 - 705
Journal Article
Current radiopharmaceuticals, 01/2019
In recent years, PET using radiolabelled amino acids has gained considerable interest as an additional tool besides MRI to improve the diagnosis of cerebral... 
Journal Article
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, ISSN 0161-5505, 03/2019, p. jnumed.119.225680
Assessment of residual tumor after resection of cerebral gliomas can be difficult with MRI and may be improved by amino acid PET. The aim of this experimental... 
Journal Article
European Radiology, ISSN 0938-7994, 07/2017, Volume 27, Issue 7, p. 2916
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00330-016-4638-2 We... 
Tyrosine | Pets | Analysis | Brain tumors | Radiation | Brain damage | Diagnostic imaging | Taxation | Metastasis | Radiotherapy | Standards
Journal Article
JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 05/2017, Volume 58, p. 1282
Objectives: With the O-(2-[F-18] fluoroethyl)-L-tyrosine (FET) PET of brain tumors, the tumor activity is determined by the tumor/brain quotient (TBR). An... 
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Tyrosine | Nuclear medicine | Brain | Therapy | Dexamethasone | Brain cancer | Brain tumors | Radioisotopes | Fluorine isotopes | Gender differences | Patients | Accumulation | Men | Positron emission tomography | Tumors
Conference Proceeding
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 03/2017, Volume 44, Issue 3, pp. 408 - 416
O-(2- super(18)F-fluoroethyl)-L-tyrosine ( super(18)F-FET) is an established tracer for the diagnosis of brain tumors with PET. This study investigates the... 
Journal Article
Neuro-Oncology, ISSN 1522-8517, 11/2017, Volume 19, Issue suppl_6, pp. vi160 - vi160
Journal Article
NeuroImage: Clinical, ISSN 2213-1582, 2018, Volume 17, pp. 491 - 497
PET using the amino-acid O-(2- F-fluoroethyl)- -tyrosine ( F-FET) is gaining increasing interest for brain tumour management. Semi-quantitative analysis of... 
18F-FET PET | Gender | Glioma | SUV | Quantitative analysis | BMI | F-FET PET | Index Medicus
Journal Article
NeuroImage. Clinical, ISSN 2213-1582, 2018, Volume 17, pp. 491 - 497
PET using the amino-acid O-(2- F-fluoroethyl)-l-tyrosine ( F-FET) is gaining increasing interest for brain tumour management. Semi-quantitative analysis of... 
Journal Article
Annals of Translational Medicine, ISSN 2305-5839, 2017, Volume 5, Issue 15, pp. 312 - 312
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.